15920062

Source:http://linkedlifedata.com/resource/pubmed/id/15920062

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014257, umls-concept:C0020557, umls-concept:C0030705, umls-concept:C0033228, umls-concept:C0205225, umls-concept:C0277785, umls-concept:C0332161, umls-concept:C0389071, umls-concept:C0441889, umls-concept:C0442818, umls-concept:C1280500
pubmed:issue	6
pubmed:dateCreated	2005-5-27
pubmed:abstractText	Improvement in endothelial function is predicted to improve insulin sensitivity, and this may be one mechanism by which fenofibrate decreases the incidence of coronary heart disease. We hypothesize fenofibrate improves endothelial function by enhancing insulin sensitivity.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin, http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate, http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0149-5992
pubmed:author	pubmed-author:HanSeung HwanSH, pubmed-author:KohKwang KonKK, pubmed-author:QuonMichael JMJ, pubmed-author:ShinEak KyunEK, pubmed-author:Yeal AhnJeongJ
pubmed:issnType	Print
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1419-24
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15920062-Adiponectin, pubmed-meshheading:15920062-Blood Flow Velocity, pubmed-meshheading:15920062-Body Mass Index, pubmed-meshheading:15920062-Brachial Artery, pubmed-meshheading:15920062-Cross-Over Studies, pubmed-meshheading:15920062-Double-Blind Method, pubmed-meshheading:15920062-Endothelium, Vascular, pubmed-meshheading:15920062-Female, pubmed-meshheading:15920062-Fenofibrate, pubmed-meshheading:15920062-Humans, pubmed-meshheading:15920062-Hyperemia, pubmed-meshheading:15920062-Hypertriglyceridemia, pubmed-meshheading:15920062-Hypolipidemic Agents, pubmed-meshheading:15920062-Insulin Resistance, pubmed-meshheading:15920062-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:15920062-Male, pubmed-meshheading:15920062-Metabolic Syndrome X, pubmed-meshheading:15920062-Middle Aged, pubmed-meshheading:15920062-Patient Selection, pubmed-meshheading:15920062-Placebos
pubmed:year	2005
pubmed:articleTitle	Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.
pubmed:affiliation	Vascular Medicine and Atherosclerosis Unit, Division of Cardiology, Gil Heart Center, Gachon Medical School, 1198 Kuwol-dong, Namdong-gu, Incheon, Korea 405-760. kwangk@ghil.com
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial